These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 4133417)

  • 1. Hypothalamic-pituitary-prolactin axis in breast cancer.
    Mittra I; Hayward JL; McNeilly AS
    Lancet; 1974 May; 1(7863):889-91. PubMed ID: 4133417
    [No Abstract]   [Full Text] [Related]  

  • 2. Hypothalamic-pituitary-thyroid axis in breast cancer.
    Mittra I; Hayward JL
    Lancet; 1974 May; 1(7863):885-9. PubMed ID: 4133416
    [No Abstract]   [Full Text] [Related]  

  • 3. Modulation of prolactin release by altered levels of thyroid hormones.
    Yamaji T
    Metabolism; 1974 Aug; 23(8):745-51. PubMed ID: 4212175
    [No Abstract]   [Full Text] [Related]  

  • 4. Prolactin release induced by synthetic thyrotrophin releasing factor in female rats.
    Deis RP; Alonso N
    J Endocrinol; 1973 Sep; 58(3):673-4. PubMed ID: 4200588
    [No Abstract]   [Full Text] [Related]  

  • 5. Stimulation of prolactin release in vivo by thyrotropin-releasing hormone (TRH) through direct action on the ectopic rat pituitary.
    Porteus SE; Malven PV
    Endocrinology; 1974 Jun; 94(6):1699-703. PubMed ID: 4208654
    [No Abstract]   [Full Text] [Related]  

  • 6. [Interrelation of thyroid hormones and prolactin].
    Gladkova AI
    Probl Endokrinol (Mosk); 1984; 30(3):79-89. PubMed ID: 6429661
    [No Abstract]   [Full Text] [Related]  

  • 7. Toward a relationship between the hypothalamic-pituitary-thyroid axis and the synthesis of serotonin.
    Shopsin B; Shenkman L; Sanghvi I; Hollander CS
    Adv Biochem Psychopharmacol; 1974; 10():279-86. PubMed ID: 4276956
    [No Abstract]   [Full Text] [Related]  

  • 8. Anterior pituitary function following hypophysectomy for breast cancer.
    Fairney A; Morgan L; Barrett A; de Souza I; Barnes G
    Clin Oncol; 1976 Jun; 2(2):121-6. PubMed ID: 821686
    [No Abstract]   [Full Text] [Related]  

  • 9. PRL, TSH, and thyroid hormones in benign breast diseases.
    Peters F; Pickardt CR; Zimmermann G; Breckwoldt M
    Klin Wochenschr; 1981 Apr; 59(8):403-7. PubMed ID: 6793771
    [No Abstract]   [Full Text] [Related]  

  • 10. Human prolactin and thyrotropin concentrations in the serums of normal and hypopituitary children before and after the administration of synthetic thyrotropin-releasing hormone.
    Foley TP; Jacobs LS; Hoffman W; Daughaday WH; Blizzard RM
    J Clin Invest; 1972 Aug; 51(8):2143-50. PubMed ID: 4626583
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The late effects of neonatal hyperthyroidism upon the hypothalamic-pituitary-thyroid axis in the rat.
    Bakke JL; Lawrence N; Wilber JF
    Endocrinology; 1974 Aug; 95(2):406-11. PubMed ID: 4212428
    [No Abstract]   [Full Text] [Related]  

  • 12. Hypopituitarism after external irradiation. Evidence for both hypothalamic and pituitary origin.
    Samaan NA; Bakdash MM; Caderao JB; Cangir A; Jesse RH; Ballantyne AJ
    Ann Intern Med; 1975 Dec; 83(6):771-7. PubMed ID: 812402
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Alteration by prolonged oral administration of a thyrotropin-releasing hormone analog, TA-0910, of the pituitary-thyroid axis in subjects with brain stroke.
    Miyashita K; Murakami M; Satoh T; Monden T; Yamada M; Iriuchijima T; Kazihara A; Mori M
    Intern Med; 1993 Sep; 32(9):681-5. PubMed ID: 8142670
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects on the pituitary-thyroid axis and prolactin secretion of single and repetitive oral doses of thyrotropin-releasing hormone (TRH).
    Rabello MM; Snyder PJ; Utiger RD
    J Clin Endocrinol Metab; 1974 Sep; 39(3):571-8. PubMed ID: 4213076
    [No Abstract]   [Full Text] [Related]  

  • 15. Hypothalamo-pituitary interrelationships in thyroid pathology, with special reference to cretinism.
    Beckers C
    Adv Exp Med Biol; 1972; 30():429-40. PubMed ID: 4196884
    [No Abstract]   [Full Text] [Related]  

  • 16. Pituitary responses to thyrotropin-releasing hormone after treatment with the breast carcinogen nitrosomethylurea: inhibition of prolactin but not thyrotropin release.
    Kieffer JD; Maloof F; Vickery AL; Mover H; Downing M; Ridgway EC
    Endocrinology; 1982 Jun; 110(6):1892-6. PubMed ID: 6804215
    [No Abstract]   [Full Text] [Related]  

  • 17. [The diencephalo-hypophyseo-thyroid axis in essential obesity. Note I. Pituitary TSH response to intravenous TRH].
    Consolo F; Laurà A; Pata P; Giannetto M; Trimarchi F
    Boll Soc Ital Biol Sper; 1975 Dec; 51(24):1908-11. PubMed ID: 821499
    [No Abstract]   [Full Text] [Related]  

  • 18. Functional evaluation of prolactin secretion: a guide to therapy.
    Friesen H; Guyda H; Hwang P; Tyson JE; Barbeau A
    J Clin Invest; 1972 Mar; 51(3):706-9. PubMed ID: 4622109
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increased serum prolactin after administration of synthetic thyrotropin releasing hormone (TRH) in man.
    Jacobs LS; Snyder PJ; Wilber JF; Utiger RD; Daughaday WH
    J Clin Endocrinol Metab; 1971 Dec; 33(6):996-8. PubMed ID: 5002718
    [No Abstract]   [Full Text] [Related]  

  • 20. The forgotten effects of thyrotropin-releasing hormone: Metabolic functions and medical applications.
    Fröhlich E; Wahl R
    Front Neuroendocrinol; 2019 Jan; 52():29-43. PubMed ID: 29935915
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.